Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:INISNASDAQ:KEQUNASDAQ:NAUTNASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINISInternational Isotopes$0.06-0.7%$0.05$0.03▼$0.08$29.48M0.73266,386 shs33,000 shsKEQUKewaunee Scientific$36.78-2.3%$35.80$30.33▼$71.33$105.79M0.5623,489 shs3,439 shsNAUTNautilus Biotechnology$0.70-2.7%$0.75$0.66▼$3.09$88.43M1.43125,967 shs305,632 shsPREPrenetics Global$7.51+7.1%$6.47$3.09▼$11.99$85.56M0.1719,146 shs13,273 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINISInternational Isotopes+6.07%-3.41%+18.80%+20.73%+48.50%KEQUKewaunee Scientific+1.59%-3.68%+0.91%-24.23%-5.43%NAUTNautilus Biotechnology+2.71%-6.74%-12.62%-32.08%-71.88%PREPrenetics Global0.00%-9.20%+12.25%+65.14%+17.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINISInternational IsotopesN/AN/AN/AN/AN/AN/AN/AN/AKEQUKewaunee Scientific1.8018 of 5 stars0.04.00.00.02.22.51.3NAUTNautilus Biotechnology2.9065 of 5 stars3.02.00.00.03.34.20.6PREPrenetics Global1.6638 of 5 stars2.53.00.00.02.40.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINISInternational Isotopes 0.00N/AN/AN/AKEQUKewaunee Scientific 0.00N/AN/AN/ANAUTNautilus Biotechnology 2.00Hold$2.13203.31% UpsidePREPrenetics Global 3.00Buy$9.0019.84% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINISInternational Isotopes$13.90M2.23$0.00 per share75.87$0.01 per share5.90KEQUKewaunee Scientific$203.76M0.51$1.24 per share29.56N/A∞NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/APREPrenetics Global$30.62M2.99N/AN/A$14.04 per share0.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINISInternational Isotopes$10KN/A0.00∞N/A0.35%1.21%0.30%8/12/2025 (Estimated)KEQUKewaunee Scientific$18.75M$5.916.22∞N/A7.99%24.66%9.76%6/24/2025 (Estimated)NAUTNautilus Biotechnology-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%6/17/2025 (Estimated)Latest INIS, KEQU, NAUT, and PRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 million4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINISInternational IsotopesN/AN/AN/AN/AN/AKEQUKewaunee ScientificN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINISInternational Isotopes0.060.990.83KEQUKewaunee Scientific0.622.161.54NAUTNautilus BiotechnologyN/A17.3617.36PREPrenetics GlobalN/A2.071.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINISInternational IsotopesN/AKEQUKewaunee Scientific32.69%NAUTNautilus Biotechnology50.71%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipINISInternational Isotopes18.10%KEQUKewaunee Scientific14.20%NAUTNautilus Biotechnology41.10%PREPrenetics GlobalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINISInternational Isotopes30526.39 million431.11 millionNot OptionableKEQUKewaunee Scientific1,0062.85 million2.45 millionNot OptionableNAUTNautilus Biotechnology130126.15 million74.30 millionOptionablePREPrenetics Global112.20 millionN/ANot OptionableINIS, KEQU, NAUT, and PRE HeadlinesRecent News About These CompaniesShort Interest in Prenetics Global Limited (NASDAQ:PRE) Increases By 46.2%June 16 at 5:14 PM | marketbeat.comPrenetics Global Limited Appoints New Independent Director to Strengthen Bitcoin StrategyJune 16 at 8:51 AM | tipranks.comEquities Analysts Set Expectations for PRE FY2026 EarningsJune 16 at 1:55 AM | americanbankingnews.comBrokers Set Expectations for PRE FY2026 EarningsJune 16 at 1:52 AM | marketbeat.comPrenetics Global reports Q1 2025 financialsJune 14 at 3:07 PM | uk.investing.comPrenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement SoonJune 14 at 3:07 PM | nasdaq.comPrenetics Global (NASDAQ:PRE) Issues Quarterly Earnings ResultsJune 12, 2025 | marketbeat.comPrenetics Global Limited (NASDAQ:PRE) Sees Large Decline in Short InterestJune 2, 2025 | marketbeat.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comPrenetics Global Limited (PRENW)March 19, 2025 | ca.finance.yahoo.comPrenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | markets.businessinsider.comPrenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | globenewswire.comPrenetics to Participate in the 37th Annual ROTH ConferenceMarch 11, 2025 | finance.yahoo.comPrenetics Reports Strong 2024 Results and Optimistic 2025 OutlookMarch 5, 2025 | tipranks.comPrenetics Global Limited Reports 93.5% Revenue Growth in Q4 2024 and Provides 2025 Financial GuidanceMarch 5, 2025 | quiverquant.comPrenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 GuidanceMarch 5, 2025 | globenewswire.comNYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPOFebruary 14, 2025 | prnewswire.comPrenetics Global Ltd trading halted, volatility trading pauseFebruary 12, 2025 | markets.businessinsider.comPrenetics Global Ltd trading resumesFebruary 12, 2025 | markets.businessinsider.comPrenetics partners with Humanity Protocol, launches crypto strategic reserveFebruary 11, 2025 | markets.businessinsider.comPrenetics Partners with Humanity Protocol to Enhance Blockchain-Based Identity Verification and Invests in Digital AssetsFebruary 11, 2025 | quiverquant.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?Amer Sports: The New ONON and DECK of Consumer Discretionary?By Leo Miller | May 28, 2025View Amer Sports: The New ONON and DECK of Consumer Discretionary?MarketBeat Week in Review – 05/26 - 05/30By MarketBeat Staff | May 31, 2025View MarketBeat Week in Review – 05/26 - 05/30INIS, KEQU, NAUT, and PRE Company DescriptionsInternational Isotopes OTCMKTS:INIS$0.06 0.00 (-0.67%) As of 03:09 PM EasternInternational Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.Kewaunee Scientific NASDAQ:KEQU$36.78 -0.87 (-2.31%) Closing price 04:00 PM EasternExtended Trading$37.16 +0.38 (+1.02%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.Nautilus Biotechnology NASDAQ:NAUT$0.70 -0.02 (-2.69%) Closing price 04:00 PM EasternExtended Trading$0.72 +0.02 (+2.63%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Prenetics Global NASDAQ:PRE$7.51 +0.50 (+7.13%) Closing price 04:00 PM EasternExtended Trading$7.50 -0.01 (-0.13%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analyst Downgrades Joby, But Overlooks Major Regulatory Wins Applied Digital: Now the High-Stakes Race to Build Begins Zscaler Upgraded: Wall Street Forecasts 26% More Upside U.S. Steel Stock Burns the Bears With Surprise Upside Move Is CrowdStrike Stock Set to Break Out or Cool Off? New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 The Bottom Is in for Powerfleet: An Intelligent Time to Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
